CVE-2008-6662

Description

AVG Anti-Virus for Linux 7.5.51, and possibly earlier, allows remote attackers to cause a denial of service (segmentation fault) or possibly execute arbitrary code via a malformed UPX compressed file, which triggers memory corruption.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 4.00% Top 15%
Third-Party Advisory marc.info Third-Party Advisory ivizsecurity.com Third-Party Advisory securityfocus.com Third-Party Advisory ibmcloud.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://marc.info/?l=bugtraq&m=122893196715523&w=2 third party advisory mailing list
http://www.vupen.com/english/advisories/2008/3461 vdb entry broken link
https://exchange.xforce.ibmcloud.com/vulnerabilities/47254 vdb entry third party advisory
http://www.securityfocus.com/bid/32749 vdb entry third party advisory
http://www.osvdb.org/51962 vdb entry broken link
http://www.ivizsecurity.com/security-advisory-iviz-sr-08014.html third party advisory

Frequently Asked Questions

What is the severity of CVE-2008-6662?
CVE-2008-6662 has been scored as a medium severity vulnerability.
How to fix CVE-2008-6662?
To fix CVE-2008-6662, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-6662 being actively exploited in the wild?
It is possible that CVE-2008-6662 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~4% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.